Xeomin, a new Botox alternative from Merz Pharmaceuticals, has been approved for use in the United States. Currently, it is approved for use in cases of blepharospasm and cervical dystonia, but physicians can use it off-label for cosmetic purposes. Soon, patients will have the choice between Botox, Dysport, and Xeomin!